Self-monitoring versus standard monitoring of oral anticoagulation

Thrombosis Research

Volumn 119, Issue 3, 2007, Pages 389-390

  Ferretti, Gianluigi ^a   Giannarelli, Diana ^a   Carlini, Paolo ^a   Felici, Alessandra ^a   Ciccarese, Mariangela ^a   Mandalà, Mario ^b   Cognetti, Francesco ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Oral anticoagulation; Self monitoring; Standard monitoring; Venous thromboembolism

Indexed keywords

ADMINISTRATION, ORAL; ANTICOAGULANTS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MONITORING, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF CARE; THROMBOEMBOLISM;

EID: 33845473511     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.08.007     Document Type: Letter

References (12)

1. Heneghan C., Alonso-Coello P., Garcia-Alamino J.M., Perera R., Meats E., and Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 367 (2006) 404-411
2. Ferretti G., Bria E., Giannarelli D., Carlini P., Felici A., Mandala M., et al. Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism. Thromb Res (Jun 13 2006) [Electronic publication ahead of print]. doi:10.1016/j.thromres.2006.04.009
3. Pini M., Aiello S., Manotti C., Pattacini C., Quintavalla R., Poli T., et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 72 2 (1994) 191-197
4. Gonzalez-Fajardo J.A., Arreba E., Castrodeza J., Perez J.L., Fernandez L., Agundez I., et al. Venographic comparison of subcutaneous low-molecular-weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. J Vasc Surg 30 (1999) 283-290
5. Lopaciuk S., Bielska-Falda H., Noszczyk W., Bielawiec M., Witkiewicz W., Filipecki S., et al. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Thromb Haemost 81 (1999) 26-31
6. Veiga F., Escriba A., Maluenda M.P., Lopez Rubio M., Margalet I., Lezana A., et al. Low-molecular weight heparin (Enoxaparin) versus oral anticoagulant therapy (Acenocumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial. Thromb Haemost 84 (2000) 559-564
7. Lopez-Beret P., Orgaz A., Fontcuberta J., Doblas M., Martinez A., Lozano G., et al. Low-molecular weight heparin versus oral anticoagulant in the long-term treatment of deep venous thrombosis. J Vasc Surg 33 (2001) 77-90
8. Meyer G., Marjanovic Z., Valcke J., Lorcerie B., Gruel Y., Solal-Celigny P., et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 162 15 (2002) 1729-1735
9. Hull R.D., Pineo G.F., Mah A.F., Brant R.F., and for the LITE Study Investigators. A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium. Blood 100 11 (2002) 148a [#556]
10. Sandercock J., Parmar M.K., Torri V., and Qian W. First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence. Br J Cancer 87 8 (2002) 815-824
11. Palareti G., Legnani C., Lee A., Manotti C., Hirsh J., D'Angelo A., et al. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost 84 5 (2000) 805-810
12. Prandoni P., Lensing A.W., Piccioli A., Bernardi E., Simioni P., Girolami B., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100 10 (2002) 3484-3488